Endpoints News ٩ أبريل ٢٠٢٦ Roche dips into DACs with existing partner C4 Therapeutics for $20M upfront
Endpoints News ٢٠ مارس ٢٠٢٦ Genentech culls muscle-preserving drug in genetic diseases, raising questions about obesity trial
Endpoints News ٩ فبراير ٢٠٢٦ #ACTRIMS26: Roche’s MS drug fenebrutinib beats Ocrevus, cutting risk of disability progression by 12%
Endpoints News ٨ يناير ٢٠٢٦ Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial
Endpoints News ٨ يناير ٢٠٢٦ Charles Fuchs leaves Roche to steer ADC pipeline at Tubulis shortly after $401M Series C
Endpoints News ٨ يناير ٢٠٢٦ Former Genentech leaders’ protein degrader startup EpiBiologics nets $107M
Endpoints News ١٠ ديسمبر ٢٠٢٥ #SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%
Endpoints News ٤ ديسمبر ٢٠٢٥ Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron